| July 2020 |
|
|
Chairwoman Johnson Comments on Final Pebble Mine Environmental Impact Statement
|
|
|
Chairwoman Johnson Applauds Inclusion of Artificial Intelligence Initiative in NDAA
|
|
|
Environment Subcommittee Chairwoman Sherrill Holds Teleconference on NOAA’s Wildfire Preparedness and COVID-19 Impacts
|
|
|
Chairwoman Johnson Comments on Weakening of National Environmental Policy Act
|
|
|
Chairwoman Johnson Opening Statement for Hearing on Bolstering DOE Technology Transfer Activities to Accelerate Economic Recovery
|
|
|
Chairwoman Fletcher Opening Statement for Hearing on Bolstering DOE Technology Transfer Activities to Accelerate Economic Recovery
|
|
|
Chairwoman Johnson Opening Statement for Hearing on COVID-19, Extreme Heat, and Environmental Justice
|
|
|
Chairwoman Johnson Demands Cooperation from Department of Commerce on Hurricane Dorian OIG Report
|
|
|
Letter to Department of Commerce Secretary Ross on Hurricane Dorian Office of Inspector General Report
|
|
|
Chairwoman Johnson Raises Concern Over Halted Hurricane Dorian IG Report
|
| June 2020 |
|
|
Chairwoman Johnson Applauds Climate Crisis Committee Action Plan
|
|
|
Committee Leaders Raise Questions After Abrupt Termination of Federal Coronavirus Research Grant
|
|
|
Letter to HHS Secretary Azar on Termination of Federal Coronavirus Research Grant
|
|
|
Committee Leaders Submit Comment on EPA’s Proposed Rule on the Review of the National Ambient Air Quality for Particulate Matter
|
|
|
Comment on EPA's Proposed Rule on the Review of the National Ambient Air Quality for Particulate Matter
|
|
|
Chairwoman Johnson Applauds Renaming NASA Headquarters after First African American Female Engineer Mary W. Jackson
|
|
|
Chairwoman Johnson Opening Statement for Hearing on R&D to Support Healthy Air Travel in COVID-19 Era
|
|
|
Chairwoman Horn Opening Statement for Hearing on R&D to Support Healthy Air Travel in COVID-19 Era
|
|
|
Chairwoman Johnson Opening Statement for Hearing on Repurposing Therapeutic Drugs for COVID-19
|
|
|
Chairman Foster Opening Statement for Hearing on Repurposing Therapeutic Drugs for COVID-19
|
